|Articles|July 1, 2001
- Pharmaceutical Technology-07-02-2001
- Volume 25
- Issue 7
The BCS: Where Do We Go From Here?
The Biopharmaceutics Classification System, which is used to regulate the bioequivalence of oral drug products, may become an essential tool in future drug development efforts.
Advertisement
Articles in this issue
about 25 years ago
Musings on the Past 25 Yearsabout 25 years ago
Reflections on Changes at FDAabout 25 years ago
Deliver the Doseabout 25 years ago
Middle-European Pharmaceutics in a Changing Worldabout 25 years ago
From Inactive Ingredients to Pharmaceutical Excipientsabout 25 years ago
Am I Going Backwards?about 25 years ago
The Filter Scene: Old and Newabout 25 years ago
Catching Up with Expert Systemsabout 25 years ago
25 Years of Change in the Parenteral Technology FieldAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The FDA Moves to Modernize Drug Manufacturing Registration
2
The Implications of Isatuximab-irfc’s FDA Approval for Multiple Myeloma
3
Overcoming Raw-Material Variability Challenges for Autologous Adoptive Cell Therapies
4
PharmTech Weekly Roundup–July 10, 2026
5